Clinical trial NCT05728723: The Effectiveness of the Android Application as a Pharmaceutical Education Tool in Hypertensive Patients
Official title: The Influence of Android Application as a Pharmaceutical Education Tool on Knowledge, Adherence, Clinical Outcome and Quality of Life of Hypertension Prolanis Patients: A Pilot Study
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Hypertension
Keywords: Knowledge
Adherence
Quality of Life
Smartphone
Pharmacist
Lead sponsor: Universitas Padjadjaran
Sponsor class: OTHER
First posted: 2023-02-15
Enrollment: 100
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NON_RANDOMIZED
Intervention model: PARALLEL
Primary purpose: PREVENTION

Brief summary: Hypertension is a worldwide public health challenge due to its high prevalence and along with increased risk of complications of other diseases that are more dangerous if not managed properly. An estimated 1.4 billion people worldwide have high blood pressure, but only 14% can control it. Knowledge of hypertension in patients with hypertension can prevent complications through hypertension treatment. Increasing knowledge can be done by providing education in the form of counseling by pharmacists to hypertensive patients. Counseling activities carried out by pharmacists can be supported by a technological approach. One of the uses in smartphone technology is by creating an android-based mobile application that can be developed to support pharmaceutical care. Education conducted by pharmacists can increase knowledge that will affect hypertension treatment adherence, and this education can also improve blood pressure control so that it can improve the quality of life. The purpose of this study is to analyze the influence of the android application as a standard pharmacist education tool on knowledge as well as adherence and therapeutic outcomes of hypertensive patients, and quality of life related to the health of hypertensive patients compared to just providing standard education by pharmacists to hypertensive patients at the Primary Health Care. The method used in this study is a Quasi-Experimental with Pretest - Posttest Control Group Design. Samples were obtained by purposive sampling method at the selected Primary Health Care as the intervention group and the selected Primary Health Care as the control group. Pharmacist provides education to intervention groups with android applications as counseling aids and in control groups only standard counseling is provided. Pre-test data collection was done by taking primary and secondary data of patients at the first meeting and post-test data collection was taken prospectively through face-to-face interviews and questionnaires on hypertensive patients participants for three months by observing the influence of android applications as counseling aids on knowledge of hypertensive diseases, adherence to antihypertensive treatment, outcome therapy and quality of life.


Eligibility criteria: Inclusion Criteria:

* Patients aged ≥ 18 years, male and female who are willing to be respondents.
* Patients diagnosed with hypertension or currently taking ≥ 1 antihypertensive drug.
* Hypertension patients who carry out routine control and receive anti-hypertensive drugs for at least 3 months at the Health Center.
* Not illiterate and owns a smartphone.
* Patients who are willing to participate in the study by signing an informed consent.

Exclusion Criteria:

* Physical and mental disabilities such as deaf, blind, and psychiatric disorders.
* The patient is pregnant
* Currently taking hormonal drugs and other routine drugs such as TB, HIV and AIDS drugs.

Primary outcomes:
measure: Knowledge about hypertension
timeFrame: At day 90 after treatment
measure: Adherence to antihypertensive treatment
timeFrame: At day 90 after treatment
Secondary outcomes:
measure: Blood pressure
timeFrame: 90 days
measure: Quality of life related to the health
timeFrame: 90 days
Other outcomes:
Locations:
city: Bandar Lampung
country: Indonesia
facility: Health Centers
state: Lampung
Study officials:
affiliation: Faculty of Pharmacy Universitas Padjadjaran Bandung
name: Abdul K Tasib, S.Si., Apt.
role: PRINCIPAL_INVESTIGATOR
affiliation: Faculty of Pharmacy Universitas Padjadjaran Bandung
name: Eli Halimah, Dr.M.Si.Apt.
role: PRINCIPAL_INVESTIGATOR
affiliation: Faculty of Pharmacy Universitas Padjadjaran Bandung
name: Irma M Puspitasari, Prof.MT.Ph.D
role: PRINCIPAL_INVESTIGATOR
References: